Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 7 Neuromyelitis Optica 2 Recurrence 1 Optic Neuritis 1 Myelitis, Transverse 1 Hemoglobinuria, Paroxysmal 1 Demyelinating Diseases 1 Atypical Hemolytic Uremic Syndrome 1 Adrenal Insufficiency 1

Interventions

ravulizumab 1 Prednisone 1 Prednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Adrenal Insufficiency × ravulizumab × Clear all

NCT07221838 2026-04-09

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡